Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Revance TherapeuticsAurinia PharmaceuticalsSynthorxOrganogenesisAkebia Therapeutics
SymbolNASDAQ:RVNCNASDAQ:AUPHNASDAQ:THORNASDAQ:ORGONASDAQ:AKBA
Price Information
Current Price$14.68$4.67$12.26$7.60$4.32
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$34.35$16.50$25.50$10.80$13.50
% Upside from Price Target134.10% upside253.32% upside107.99% upside42.11% upside212.50% upside
Trade Information
Market Cap$537.17 million$387.04 million$420.43 million$716.12 million$512.30 million
Beta1.141.11N/AN/A1.43
Average Volume344,0621,141,32395,56264,903835,347
Sales & Book Value
Annual Revenue$3.73 million$460,000.00N/A$193.45 million$207.74 million
Price / Sales173.50957.25N/A3.722.47
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.94 per share$1.32 per share$6.72 per share$0.52 per share$5.44 per share
Price / Book3.723.54N/A14.620.79
Profitability
Net Income$-142,570,000.00$-64,120,000.00$-56,610,000.00$-64,830,000.00$-143,590,000.00
EPS($3.94)($0.76)($6.59)N/A($2.44)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-3,745.97%-13,231.97%N/AN/A-75.64%
Return on Equity (ROE)-79.28%-50.08%N/AN/A-36.92%
Return on Assets (ROA)-54.14%-40.69%N/AN/A-22.10%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%N/AN/A3.78%0.06%
Current Ratio5.59%18.98%22.77%1.51%1.70%
Quick Ratio5.59%18.98%22.77%1.14%1.05%
Ownership Information
Institutional Ownership Percentage98.75%31.13%65.62%1.68%71.86%
Insider Ownership Percentage5.20%N/A53.20%70.40%2.66%
Miscellaneous
Employees1703939700324
Shares Outstanding44.10 million94.29 million32.27 million94.60 million118.86 million
Next Earnings Date11/7/2019 (Estimated)11/14/2019 (Estimated)11/7/2019 (Estimated)11/12/2019 (Confirmed)11/14/2019 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
 Revance TherapeuticsAurinia PharmaceuticalsSynthorxOrganogenesisAkebia Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel